Sono-Tek Corp (SOTK) Q3 2025 Filing Summary
Business Context and Reporting Period
Sono-Tek Corp is a global leader in designing and manufacturing ultrasonic coating systems for microelectronics, alternative energy, medical, and industrial markets. This Form 10-Q covers the quarterly period ended November 30, 2024 (Third Quarter of Fiscal Year 2025) and the nine-month period ended on the same date. The company operates as a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | 9 Months 2025 | 9 Months 2024 |
|---|---|---|---|---|
| Net Sales | $5.19 million | $5.69 million | $15.38 million | $14.93 million |
| Gross Profit | $2.34 million | $2.93 million | $7.31 million | $7.50 million |
| Gross Margin | 45.1% | 51.4% | 47.5% | 50.2% |
| Operating Income | $0.20 million | $0.72 million | $0.72 million | $1.19 million |
| Net Income | $0.27 million | $0.69 million | $0.95 million | $1.28 million |
| Diluted EPS | $0.02 | $0.04 | $0.06 | $0.08 |
| Cash & Equivalents | $8.10 million (Nov 30, 2024) | |||
| Marketable Securities | ||||
| Total Liquidity | $12.68 million | |||
| Debt | $0 (No outstanding borrowings) | |||
| Working Capital | $13.20 million |
Material Changes vs. Prior Period
- Revenue: Q3 sales declined 9% year-over-year (YoY) to $5.19 million, driven by lower sales in Industrial and Medical markets and reduced revenue from US and EMEA regions. However, the nine-month period showed a 3% increase to $15.38 million.
- Profitability: Gross margin compressed by 600 basis points in Q3 (45% vs. 51% prior year) due to product mix, higher international sales with distributor discounts, and the reclassification of engineering labor costs to Cost of Goods Sold (COGS).
- Operating Expenses: Total operating expenses decreased 3% in Q3, primarily due to a 19% reduction in R&D spending. However, G&A expenses increased 24% YoY due to higher salaries, legal/audit fees, and stock-based compensation.
- Market Performance: Alternative/Clean Energy sales surged 42% in Q3 and 63% over nine months, offsetting declines in Medical (-33% Q3) and Industrial (-59% Q3) sectors.
- Liquidity: Cash and cash equivalents increased significantly by $5.96 million over the nine-month period, largely due to the liquidation of marketable securities and strong operating cash flow.
Outlook, Risks, and Management Commentary
- Backlog: Combined equipment and service backlog remained strong at $10.56 million as of November 30, 2024, a slight decrease from $10.67 million a year ago.
- Strategic Shift: Management highlights a successful transition from selling components to high-value complete machine solutions, with average selling prices increasing significantly (some systems exceeding $1 million).
- Geographic Trends: APAC sales grew 64% in Q3, driven by South Korea and India. Conversely, sales to China continue to decline due to local competition and "Made in China" mandates, though management notes this no longer materially impacts overall performance.
- Risks: Key risks include customer concentration (one customer represented 23% of Q3 sales), supply chain pressures, and the impact of tariffs. There are no pending legal actions.
- Accounting Changes: The company reclassified CEO salary from Sales to G&A and moved specific engineering labor costs to COGS, impacting margin calculations.
Investor Verification Checklist
- Margin Sustainability: Verify if the 600 bps gross margin compression in Q3 is a one-time impact of cost reclassification or a structural shift due to product mix and international pricing.
- Customer Concentration: Assess the risk associated with the top customer accounting for 23% of Q3 sales and 14% of nine-month sales.
- China Exposure: Confirm the trajectory of sales in China and the effectiveness of growth in other APAC regions (Korea, India) in offsetting these losses.
- Backlog Conversion: Monitor the conversion rate of the $10.56 million backlog into revenue in the upcoming quarters.
- Cash Deployment: Review the company's strategy for its $12.68 million liquidity position, given the lack of debt and current investment in low-risk securities.